<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005251A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005251</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13933526</doc-number><date>20130702</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>11150645.7</doc-number><date>20110111</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>113</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>Q</subclass><main-group>1</main-group><subgroup>68</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>113</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>Q</subclass><main-group>1</main-group><subgroup>6883</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514 44 A</main-classification><further-classification>536 245</further-classification><further-classification>435  612</further-classification></classification-national><invention-title id="d0e61">MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>PCT/NL2012/050011</doc-number><date>20120110</date></document-id><parent-status>PENDING</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>13933526</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>61431656</doc-number><date>20110111</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61431667</doc-number><date>20110111</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61521917</doc-number><date>20110810</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61521931</doc-number><date>20110810</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61522346</doc-number><date>20110811</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61540640</doc-number><date>20110929</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>InteRNA Technologies B.V.</orgname><address><city>Nijmegen</city><country>NL</country></address></addressbook><residence><country>NL</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>WEIJZEN</last-name><first-name>Sanne</first-name><address><city>Bilthoven</city><country>NL</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>SCHAAPVELD</last-name><first-name>Roeland Quirinus Jozef</first-name><address><city>Bussum</city><country>NL</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>BOURAJJAJ</last-name><first-name>Meriem</first-name><address><city>Almere</city><country>NL</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>VAN HAASTERT</last-name><first-name>Rick Jan</first-name><address><city>Amersfoort</city><country>NL</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>GRIFFIOEN</last-name><first-name>Arjan Willem</first-name><address><city>Heemstede</city><country>NL</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>VAN BEIJNUM</last-name><first-name>Judith Rosina</first-name><address><city>Hilversum</city><country>NL</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>CUPPEN</last-name><first-name>Edwin Pieter Johan Gerard</first-name><address><city>Bilthoven</city><country>NL</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>BEREZIKOV</last-name><first-name>Eugene</first-name><address><city>Haren</city><country>NL</country></address></addressbook></inventor><inventor sequence="08" designation="us-only"><addressbook><last-name>Ludovicus VAN PUIJENBROEK</last-name><first-name>Andreas Alphons Franciscus</first-name><address><city>Boxtel</city><country>NL</country></address></addressbook></inventor><inventor sequence="09" designation="us-only"><addressbook><last-name>GOMMANS</last-name><first-name>Willemijn Maria</first-name><address><city>Voorschoten</city><country>NL</country></address></addressbook></inventor><inventor sequence="10" designation="us-only"><addressbook><last-name>BABAE</last-name><first-name>Negar</first-name><address><city>Utrecht</city><country>NL</country></address></addressbook></inventor><inventor sequence="11" designation="us-only"><addressbook><last-name>VAN NOORT</last-name><first-name>Petronella Innocentia</first-name><address><city>Megen</city><country>NL</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>InteRNA Technologies B.V.</orgname><role>03</role><address><city>Nijmegen</city><country>NL</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.</p></abstract></us-patent-application>